Entries by aeonastron_ad

ologen™ Collagen Matrix Implantation is viable to assist Treatment of Scleromalacia after Periocular Surgery.

A long-term study conducted in South Korea with a total of 26 areas of 25 eyes in 25 patients were carried out. Post-operative follow-up of 8-12 months concluded that no eyes showed recurrence or specific complications related to Ologen such as implant extrusion or allergic reaction. Minor complications such as flap vessel engorgement and flap […]

A RETROSPECTIVE STUDY DISCOVERED 41.7% HIGHER RATE OF COMPLETE SUCCESS OF OLOGEN-AUGMENTED AHMED GLAUCOMA VALVE IMPLANTATION THAN CONVENTIONAL METHOD.

This study included a total of 20 eyes of 20 glaucoma patients, who were followed for at least 1-year after undergoing AGV implantation. In 12 eyes of 12 patients, conventional AGV (CAGV) surgery was performed, while in 8 eyes of 8 patients, ologen-augmented AGV (OAGV) implantation was performed. The rate of complete success was significantly […]

ologen™ CM Patch Grafts Improve Ahmed Valve Treatment Success Rates by 127%

ologen™ CM Patch Grafts Improve Ahmed Valve Treatment Success Rates by 127%   According to a new 6-month Korean study published in the journal Investigative Ophthalmology & Visual Science, success rates of Ahmed Glaucoma Valve (AGV) surgeries soar and post-operative anti-glaucoma medication needs drop when said surgeries are performed in combination with biodegradable collagen patch […]

New Horizons: “Novel Applications for ologen™ Collagen Matrix” at the 5th WGC, July 2013, Vancouver, Canada

New Horizons: “Novel Applications for ologen™ Collagen Matrix” at the 5th WGC, July 2013, Vancouver, Canada The Aeon Astron sponsored symposium “New Horizons: Novel Applications for ologen™ Collagen Matrix” held at the fifth World Glaucoma Congress, Vancouver, met with great success. The symposium featured the US experience with ologen™ Collagen Matrix (Dr David Godfrey, Glaucoma […]

India as leading country in the application of ologen™ Collagen Matrix and its combined use

India as leading country in the application of ologen™ Collagen Matrix and its combined use 2013 APAO-AIOS symposia recognize India as leading country in the application of ologen™ Collagen Matrix and its combined use with other compounds. The Aeon Astron sponsored symposium at the 2013 APAO-AIOS Joint Congress1 “Breakfast Debate: ologen™ Collagen Matrix or MMC for Glaucoma […]

EuroTimes And EyeWorld News on ologen™ Collagen Matrix

EuroTimes And EyeWorld News on ologen™ Collagen Matrix   ologen™ Collagen Matrix as An Alternative to MMC And The Patch Grafts in Glaucoma Surgery The monthly magazine of ESCRS1, EuroTimes (Vol 17; 11, Nov 2012), and the official news magazine of ASCRS2, EyeWorld (Vol 17; 9, Sept 2012), cover the news on ologen™ Collagen Matrix […]

Expansive applications of ologen™ Collagen Matrix in eye tissue repair and grafting widely discussed at 2012 EGS

Expansive applications of ologen™ Collagen Matrix in eye tissue repair and grafting widely discussed at 2012 EGS At the 10th European Glaucoma Society Congress in Copenhagen (June 17 – 22, 2012 ), Prof. T.S. Dietlein (Germany) and Dr. Hans J. Schuitmaker (The Netherlands) called for the need of ready-to-use anti-fibrotics and tissue repair grafting in […]